Evidence map›Paper›PMID 25713416›Full record

ArticleThe Journal of cell biology2015

Regulation of C-X-C chemokine gene expression by keratin 17 and hnRNP K in skin tumor keratinocytes.

Byung Min Chung, Artem Arutyunov, Erika Ilagan, Nu Yao, Marsha Wills-Karp, Pierre A Coulombe

Abstract read
In one paragraph

Article in The Journal of cell biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. hnRNP K induces HPV16 oncogene expression and promotes cervical cancerization.Journal of cancer research and clinical oncology · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Stress Keratin 17 Expression in Head and Neck Cancer Contributes to Immune Evasion and Resistance to Immune-Checkpoint Blockade.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022
    Article
  18. Article
  19. Increased expression ofFrontiers in genetics · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Byung Min ChungDepartment of Biochemistry and Molecular Biology and Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health; and Department of Biological Chemistry, Department of Dermatology, and Department of Oncology, School of Medicine, Johns Hopkins University, MD 21205.
Artem ArutyunovDepartment of Biochemistry and Molecular Biology and Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health; and Department of Biological Chemistry, Department of Dermatology, and Department of Oncology, School of Medicine, Johns Hopkins University, MD 21205.
Erika IlaganDepartment of Biochemistry and Molecular Biology and Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health; and Department of Biological Chemistry, Department of Dermatology, and Department of Oncology, School of Medicine, Johns Hopkins University, MD 21205.
Nu YaoDepartment of Biochemistry and Molecular Biology and Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health; and Department of Biological Chemistry, Department of Dermatology, and Department of Oncology, School of Medicine, Johns Hopkins University, MD 21205.
Marsha Wills-KarpDepartment of Biochemistry and Molecular Biology and Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health; and Department of Biological Chemistry, Department of Dermatology, and Department of Oncology, School of Medicine, Johns Hopkins University, MD 21205.
Pierre A CoulombeDepartment of Biochemistry and Molecular Biology and Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health; and Department of Biological Chemistry, Department of Dermatology, and Department of Oncology, School of Medicine, Johns Hopkins University, MD 21205 Department of Biochemistry and Molecular Biology and Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health; and Department of Biological Chemistry, Department of Dermatology, and Department of Oncology, School of Medicine, Johns Hopkins University, MD 21205 Department of Biochemistry and Molecular Biology and Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health; and Department of Biological Chemistry, Department of Dermatology, and Department of Oncology, School of Medicine, Johns Hopkins University, MD 21205 Department of Biochemistry and Molecular Biology and Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health; and Department of Biological Chemistry, Department of Dermatology, and Department of Oncology, School of Medicine, Johns Hopkins University, MD 21205 coulombe@jhu.edu.
Pediatrics and Genetics · USJohns Hopkins University · USJohns Hopkins Medicine · US

Funding

TRAINING IN AREAS FUNDAMENTAL TO CANCER RESEARCHT32CA009110 · NCI · JOHNS HOPKINS UNIVERSITY · PI MATUNIS, MICHAEL J., WEERARATNA, ASHANI T · 1985 to 2025
$13.1M
Non-Canonical Functions of Keratin Proteins in SkinR01AR044232 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COULOMBE, PIERRE · 1996 to 2020
$8.6M
Keratins as novel determinants of tumor biologyR01CA160255 · NCI · JOHNS HOPKINS UNIVERSITY · PI COULOMBE, PIERRE · 2011 to 2017
$1.9M
NCI NIH HHS CA160255NCI NIH HHS R01 CA160255NCI NIH HHS T32 CA009110NCI NIH HHS T32CA009110NIAMS NIH HHS AR44232 ANDNIAMS NIH HHS R01 AR044232
6 · The paper itself

Abstract

High levels of the intermediate filament keratin 17 (K17) correlate with a poor prognosis for several types of epithelial tumors. However, the causal relationship and underlying mechanisms remain undefined. A recent study suggested that K17 promotes skin tumorigenesis by fostering a specific type of inflammation. We report here that K17 interacts with the RNA-binding protein hnRNP K, which has also been implicated in cancer. K17 is required for the cytoplasmic localization of hnRNP K and for its role in regulating the expression of multiple pro-inflammatory mRNAs. Among these are the CXCR3 ligands CXCL9, CXCL10, and CXCL11, which together form a signaling axis with an established role in tumorigenesis. The K17-hnRNP K partnership is regulated by the ser/thr kinase RSK and required for CXCR3-dependent tumor cell growth and invasion. These findings functionally integrate K17, hnRNP K, and gene expression along with RSK and CXCR3 signaling in a keratinocyte-autonomous axis and provide a potential basis for their implication in tumorigenesis.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsChemokines, CXCHeLa CellsHeterogeneous-Nuclear Ribonucleoprotein KHumansKeratinocytesKeratinsMice, KnockoutNeoplasm ProteinsReceptors, CXCR3Signal TransductionSkin NeoplasmsChemokines, CXCCXCR3 protein, humanCxcr3 protein, mouseHeterogeneous-Nuclear Ribonucleoprotein KKeratinsKrt17 protein, mouseNeoplasm ProteinsReceptors, CXCR3

Identifiers

PMID25713416
PMCPMC4347647
OpenAlexW2102346660

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.